Sellas Life Sciences: A Single Hazard Ratio Holds the Key to a 950% Rally
The entire case for Sellas Life Sciences now rests on one number: a hazard ratio of 0.636 or better. That is the statistical threshold its phase 3 REGAL trial must...
Top Stories
Latest financial market updates and expert analysis
AI & Quantum Computing
Under ‘Project Fuji,’ SAP Slashes 10,000 Jobs in a Radical Bid to Halt a 31% Rout
AI & Quantum Computing
View All
Defense & Aerospace
View All
Cryptocurrency
View All
Banking & Finance
View All
Latest News
Dividends
Mutares Heads Into AGM With BaFin and Covenant Clearance, but Performance Dividend Stays on Hold
Mutares enters its annual general meeting in Munich on Thursday with two significant overhangs lifted — the BaFin has closed...
Analysis
Deutsche Telekom Shares Bounce From 52-Week Low as T-Mobile US Rally Offsets Barclays Price Target Cut
The tug-of-war between bearish analyst calls and positive news from across the Atlantic is playing out in real time on...
AI & Quantum Computing
Nvidia’s New Calculus: From Chip Sales to Recurring Revenue as Market Tests Its Transformation
Nvidia is rewriting its growth playbook, and the market is still trying to decide whether the new plot is a...
Analysis
BMW Shares Recover as US Sales Jump 13% and Bernstein Sees 85-Euro Path Despite China Drag
BMW’s sprawling plant in Spartanburg, South Carolina, is emerging as a strategic counterweight to the turmoil in China’s auto market....
Dividends
VanEck Launches Accumulation Ex-US Dividend ETF as Flagship Fund Enforces 5% Cap on Top Holdings
VanEck has expanded its dividend lineup with a new accumulation share class that excludes American equities entirely, while the flagship...
DAX
Insider Bets Fuel Rheinmetall’s Bounce as Technical Roadblocks Await
When a company’s own top brass start buying shares, the market tends to sit up and take notice. At Rheinmetall,...
Asian Markets
BYD’s Two-Front Battle: Speed in Europe, Technology at Home as Shares Languish Near Lows
BYD is running a race on two continents. In Europe, the Chinese electric-vehicle giant is scrambling to secure a second...
Analysis
MSCI World ETF: Morningstar Gold Rating Endures as Tech Turmoil Spurs $253 Million Outflow
The iShares MSCI World ETF has secured Morningstar’s highest rating once again, but the accolade arrives during a period of...
Automotive & E-Mobility
Mercedes-Benz Stock Flickers Higher But Deep Losses Dwarf Classic Glamour and Green F1 Ambitions
Even a triple victory at the prestigious Hillsborough Concours d’Elegance could not lift the mood around Mercedes-Benz for long. The...
Analysis
Ocugen’s Summer of Data: Short Sellers Stand at 26% as Gene Therapy Milestones Converge
With nearly 26% of its free float sold short and a 30-day annualized volatility above 67%, Ocugen is anything but...